Cover Image

Expert group calls for re‐establishing MAOIs in treatment protocols

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	The Brown University Psychopharmacology Update
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological treatments for psychotic depression
by: Y. W. Francis Lam
Published: (2024)

Concurrent metformin improves adherence to SGA treatment
Published: (2026)

Esketamine monotherapy efficacious in treatment‐resistant depression
Published: (2025)

Intravenous hydroxyzine shows promise for treatment of delirium
Published: (2025)

Depression study shows influence of patients' treatment expectancies
Published: (2025)

Oral formulation of ketamine effective for treatment‐resistant depression
Published: (2024)

Benefits of buprenorphine over methadone offset by lower treatment retention
Published: (2026)

Decision‐support tool shows promise for treatment retention in depression
Published: (2026)

Psilocybin shows mixed results for patients with treatment‐resistant depression
Published: (2026)

Ileus, pneumonia among most burdensome effects of clozapine treatment
Published: (2024)

Review questions sustained efficacy of esketamine in treatment‐resistant depression
Published: (2025)

Adding behavioral therapy does not enhance buprenorphine treatment of OUD
Published: (2025)

Review finds VMAT‐2 inhibitors promising for treatment of psychosis
Published: (2024)

When both treatments unblinded, psychedelics not more effective than antidepressants
Published: (2026)

Ketamine shows long‐term benefit in patients with treatment‐resistant depression
Published: (2026)

Ketamine outperforms ECT on cognitive function in patients with treatment‐resistant depression
Published: (2026)

Umbrella review finds several ADHD treatments efficacious in short term
Published: (2026)

SSRI, SNRI augmentation of clozapine reduces relapse in treatment‐resistant schizophrenia
Published: (2025)

Meta‐analysis suggests risk of psychosis from stimulant treatment for ADHD
Published: (2025)

Combining MRI, clinical data has predictive value in sertraline treatment
Published: (2024)

Study finds gabapentinoid treatment does not elevate risk of self‐harm
Published: (2025)

Control group improvement lower in psilocybin trials for depression
Published: (2025)

Anti‐inflammatory treatment could help improve symptoms in some patients with depression
Published: (2026)

Study finds low correspondence between known genetic variations and treatment targets
Published: (2025)

Second‐line strategies more effective than dose optimization in depression treatment
Published: (2025)

Quetiapine augmentation more effective than lithium in treatment‐resistant depression trial
Published: (2025)

Review: Research does not support most promoted medical uses of cannabis
Published: (2026)

Approvals
Published: (2026)

Clozapine‐induced third‐degree atrioventricular block and respiratory failure
by: Y. W. Francis Lam
Published: (2026)

Impact of maternal acetaminophen use on child neurodevelopment
by: Y. W. Francis Lam
Published: (2026)

Meta‐analysis finds little benefit from cannabinoids for behavioral disorders
Published: (2026)

Network meta‐analysis finds dexmedetomidine broadly effective for postoperative delirium
Published: (2026)

Clozapine concentration and adverse reactions: Impact of smoking
by: Y. W. Francis Lam
Published: (2026)

Legal analysis assails FDA's lowering of standards for drug approval
Published: (2026)

Study of young psychiatric patients shows potential preventive benefit of doxycycline
Published: (2026)

Alcohol use history predicts antidepressant response to ketamine
Published: (2026)

Your Medication Information
Published: (2026)

DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder
Published: (2026)

Cohort study: No causal link between psychotropic exposure and obstetric complications
Published: (2026)

Antipsychotic dose reduction/discontinuation in first‐episode psychosis carries short‐term risks
Published: (2026)